Literature DB >> 12559846

Identification and characterization of 13 new mutations in mucopolysaccharidosis type I patients.

Ursula Matte1, Gouri Yogalingam, Doug Brooks, Sandra Leistner, Ida Schwartz, Luciane Lima, Denise Y Norato, Jaime M Brum, Clare Beesley, Bryan Winchester, Roberto Giugliani, John J Hopwood.   

Abstract

In this study we have investigated a group of 29 Brazilian patients, who had been diagnosed with the lysosomal storage disorder, Mucopolysaccharidosis type I (MPS-I). MPS I is caused by a deficiency in the lysosomal hydrolase, alpha-L-iduronidase. Ninety percent of the MPS I patients in this study were genotyped and revealed 10 recurrent and thirteen novel IDUA gene mutations. Eight of these new mutations and three common mutations W402X, P533R, and R383H were individually expressed in CHO-K1 cells and analyzed for alpha-L-iduronidase protein and enzyme activity. A correlation was observed between the MPS I patient clinical phenotype and the associated mutant alpha-L-iduronidase protein/enzyme activity expressed in CHO-K1 cells. This was the first time that Brazilian MPS I patients had been thoroughly analyzed and highlighted the difficulties of mutation screening and clinical phenotype assessment in populations with high numbers of unique mutations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12559846     DOI: 10.1016/s1096-7192(02)00200-7

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  31 in total

1.  Cardiac disease in mucopolysaccharidosis type I attributed to catecholaminergic and hemodynamic deficiencies.

Authors:  Nathan J Palpant; Fikru B Bedada; Brandon Peacock; Bruce R Blazar; Joseph M Metzger; Jakub Tolar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-12       Impact factor: 4.733

Review 2.  Gene therapy for mucopolysaccharidosis.

Authors:  Katherine P Ponder; Mark E Haskins
Journal:  Expert Opin Biol Ther       Date:  2007-09       Impact factor: 4.388

3.  Network Analysis Reveals Proteins Associated with Aortic Dilatation in Mucopolysaccharidoses.

Authors:  Thiago Corrêa; Bruno César Feltes; Esteban Alberto Gonzalez; Guilherme Baldo; Ursula Matte
Journal:  Interdiscip Sci       Date:  2021-01-21       Impact factor: 2.233

4.  Mucopolysaccharidosis type I, II and VI and response to enzyme replacement therapy: Results from a single-center case series study.

Authors:  José Francisco da Silva Franco; Regina El Dib; Arnav Agarwal; Diogo Soares; Noala Vicensoto Moreira Milhan; Lilian Maria José Albano; Chong Ae Kim
Journal:  Intractable Rare Dis Res       Date:  2017-08

5.  Crystallization, X-ray diffraction analysis and SIRAS phasing of human α-L-iduronidase.

Authors:  Nobuo Maita; Hisaaki Taniguchi; Hitoshi Sakuraba
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-10-30

6.  Molecular characterization of 355 mucopolysaccharidosis patients reveals 104 novel mutations.

Authors:  Laura M Pollard; Julie R Jones; Tim C Wood
Journal:  J Inherit Metab Dis       Date:  2012-09-14       Impact factor: 4.982

7.  Epidemiology of mucopolysaccharidoses.

Authors:  Shaukat A Khan; Hira Peracha; Diana Ballhausen; Alfred Wiesbauer; Marianne Rohrbach; Matthias Gautschi; Robert W Mason; Roberto Giugliani; Yasuyuki Suzuki; Kenji E Orii; Tadao Orii; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2017-05-26       Impact factor: 4.797

8.  Abnormal polyamine metabolism is unique to the neuropathic forms of MPS: potential for biomarker development and insight into pathogenesis.

Authors:  Christian Hinderer; Nathan Katz; Jean-Pierre Louboutin; Peter Bell; Jakub Tolar; Paul J Orchard; Troy C Lund; Mohamad Nayal; Liwei Weng; Clementina Mesaros; Carolina F M de Souza; Amauri Dalla Corte; Roberto Giugliani; James M Wilson
Journal:  Hum Mol Genet       Date:  2017-10-01       Impact factor: 6.150

9.  Structural study on mutant alpha-L-iduronidases: insight into mucopolysaccharidosis type I.

Authors:  Kanako Sugawara; Seiji Saito; Kazuki Ohno; Torayuki Okuyama; Hitoshi Sakuraba
Journal:  J Hum Genet       Date:  2008-03-14       Impact factor: 3.172

10.  Improved retroviral vector design results in sustained expression after adult gene therapy in mucopolysaccharidosis I mice.

Authors:  Ramin Sedaghat Herati; Xiucui Ma; Mindy Tittiger; Kevin K Ohlemiller; Attila Kovacs; Katherine P Ponder
Journal:  J Gene Med       Date:  2008-09       Impact factor: 4.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.